Neurolixis is a clinical-stage biotechnology company focused on discovering and developing small-molecule therapeutics for neurological and neuropsychiatric disorders. The company advances a pipeline of compounds designed to modulate neurotransmitter systems with the goal of improving motor, cognitive, and behavioral symptoms, and engages in preclinical research, clinical development, and strategic collaborations to progress its programs.
Leadership & Board
Current Number of Employees5
Current LinkedIn Followers1,713
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$15K
Total Amount Raised$15K
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$15K
Latest Funding Amount$15K
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Neurolixis had 5 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
5Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Neurolixis had 1,713 followers as of September 28, 2026. The number of followers increased by 0 (0.00%) week-over-week.
1,713Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 18, 2013
Seed Round
$15.00K
―
Similar Companies
A snapshot of private companies similar to Neurolixis, helping you discover and navigate related company profiles.